Empire Genomics, LLC — Form D/A
Empire Genomics, LLC of BUFFALO, NY, a company, filed a Form D amendment with the SEC on 2014-11-19. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2014-11-19
- Form: D/A
- Accession: 0001608855-14-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.3M
- Remaining: $750K
- Investors: 4
- Date of first sale: 2014-06-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-220606
Issuer
- Name: Empire Genomics, LLC
- CIK: 0001608855
- Entity type: Limited Liability Company
- Jurisdiction: NEW YORK
- Address: 700 MICHIGAN ST., SUITE 200, BUFFALO, NY, 14203
- Phone: 716-856-3857
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Edward Chait | Director | Buffalo, NY |
| Michael B Sexton | Director | Buffalo, NY |
| Anthony Johnson | Director | Dania, FL |
| Anthony Johnson | Executive Officer | Dania, FL |
| Anthony Johnson | Promoter | Dania, FL |
| Daniel Penberthy | Director | Woburn, MA |
| Norma Nowak | Director | Buffalo, NY |
Other filings by this issuer (2)
More